Breakthrough Laboratory Device Revolutionizes Cannabinoid Extraction and Neurodegenerative Protein Analysis

A groundbreaking scientific achievement has emerged from an international team of researchers following the successful registration of a United Kingdom design patent titled "Laboratory Equipment for Efficient Cannabinoid Extraction with Neurodegenerative Protein Spectroscopy." The patented system represents a major advancement in analytical chemistry, biomedical instrumentation, pharmaceutical research, and neurodegenerative disease analysis, fields that increasingly rely on precision laboratory technologies capable of handling complex biochemical processes in integrated environments. The design, officially registered with the UK Intellectual Property Office under Design No. 6490817 in December 2025, introduces a novel laboratory instrument that combines chemical extraction and protein spectroscopy within a single unified platform.

For decades, laboratories studying cannabinoids and neurodegenerative proteins have depended on multiple separate instruments for extraction, analysis, and spectroscopic characterization. This fragmented workflow often results in delays, higher contamination risks, and reduced analytical accuracy. The newly patented instrument addresses these challenges by integrating these processes into one compact laboratory system capable of performing extraction and advanced optical analysis within a single device. According to the patent documentation, the system is designed as a benchtop analytical instrument integrating cannabinoid extraction mechanisms with spectroscopic analysis modules used to investigate neurodegenerative protein structures.

The innovation lies in the device's architecture. At its core is a sealed cannabinoid extraction chamber, engineered with stainless steel components capable of operating under controlled temperature and pressure conditions. Within this chamber, cannabinoid compounds can be extracted from plant materials using precisely regulated heating, agitation, and solvent handling systems. Sensors monitor pressure, temperature, and solvent flow in real time, ensuring that the extraction process remains both safe and reproducible. These chemical extraction operations are governed by an embedded electronic control system that coordinates heating, fluid flow, and analytical measurement parameters simultaneously.

What makes the invention particularly remarkable is the integration of a neurodegenerative protein spectroscopy subsystem within the same instrument. After extraction or sample preparation, proteins associated with neurological disorders can be analyzed through an optical spectroscopy module built into the device. This subsystem uses precision light sources, optical lenses, mirrors, and detectors to measure the molecular signatures of proteins. The optical configuration allows researchers to observe biochemical changes linked to diseases such as Alzheimer's or Parkinson's without transferring samples to another instrument. The elimination of sample transfer significantly reduces contamination risk while improving analytical precision and reproducibility.

The invention also introduces a sophisticated electronic and computational control environment. A centralized microcontroller coordinates the extraction chamber, optical detection module, sensors, and user interface. Through a human-machine interface featuring a digital display and interactive controls, researchers can monitor experimental conditions, view spectroscopic results, and adjust extraction parameters in real time. The design integrates power management, communication buses, signal processing circuits, and safety interlocks, ensuring stable and safe operation during laboratory experiments. This combination of mechanical engineering, analytical chemistry, and digital instrumentation transforms the device into a comprehensive biochemical research platform rather than a single-purpose tool.

The attached figure illustrates the integrated architecture of the patented laboratory device. The system combines an extraction chamber, solvent handling components, and an optical spectroscopy module within a compact benchtop instrument. A central display interface allows researchers to monitor extraction parameters and spectroscopic results simultaneously. The extraction module operates alongside the spectroscopy subsystem so that biochemical samples can be analysed immediately after preparation. This unified configuration reduces experimental complexity, enhances measurement reliability, and enables faster scientific workflows in biomedical laboratories.

One of the scientists behind this breakthrough, Joshua Blessing Animasaun, is an internationally trained analytical chemist whose work bridges academic research, industrial quality assurance, and advanced chemical detection technologies. Animasaun holds a Master of Science in Chemistry from Middle Tennessee State University in the United States and a Bachelor's degree in Industrial Chemistry from the University of Ilorin, Nigeria. His professional experience includes working as a Research Assistant at the Vanderbilt University Medical Center, where he contributed to studies on respiratory virus transmission networks connected to the U.S. Centers for Disease Control and Prevention. His laboratory work involved molecular analysis techniques such as RT-PCR testing, RNA extraction, and high-precision biosafety laboratory procedures.

Animasaun's research background in Cannabinoid Chemistry played a critical role in shaping the patented invention. During his graduate research, he investigated methods for optimizing Cannabinoid extraction using microwave-assisted and Ultrasonication techniques combined with analytical instrumentation such as Gas Chromatography–Mass Spectrometry (GC-MS) and Liquid Chromatography–Mass Spectrometry (LC-MS). His work involved developing extraction protocols, evaluating solvent efficiencies, and analysing the chemical profiles of cannabis compounds. These investigations formed part of his conference presentations at international scientific meetings, including the Pittcon conference and the SciX Conference in the United States.

Speaking about the invention, Animasaun explained how the project brought together expertise from different scientific disciplines.

"This invention grew out of a need we repeatedly encountered in research laboratories," he said. "Cannabinoid extraction and biochemical analysis are often performed on different instruments, which increases time, cost, and the possibility of experimental errors. Our goal was to design a system where extraction and spectroscopic analysis could occur within the same platform. By integrating these functions, we created a more efficient analytical workflow that improves reproducibility and opens new possibilities for studying both cannabinoids and neurodegenerative proteins."

He further emphasized the broader implications of the technology for biomedical research. "The device provides a platform that can accelerate research in several areas simultaneously," Animasaun added. "It supports cannabinoid science, pharmaceutical development, and neurological disease studies. The ability to analyse protein structures immediately after extraction or sample preparation offers researchers a faster and more reliable pathway to understanding molecular interactions involved in neurodegenerative disorders."

Animasaun also reflected on the collaborative nature of the project and the importance of interdisciplinary innovation.

"Scientific progress rarely happens in isolation," he noted. "This invention represents the convergence of analytical chemistry, optical spectroscopy, mechanical engineering, and biomedical research. Each of these disciplines contributed to the final design, and the result is a laboratory instrument that brings multiple analytical capabilities into one coherent system."

The significance of the patented design extends beyond academic research. Integrated analytical systems like this one have the potential to influence pharmaceutical development, biotechnology research, and clinical diagnostics. As the global scientific community intensifies efforts to understand complex neurological diseases and the therapeutic potential of cannabinoids, technologies capable of producing reliable biochemical data quickly and safely will become increasingly valuable.

By merging extraction technology with advanced spectroscopic detection, the patented instrument demonstrates how modern laboratory equipment is evolving toward integrated analytical platforms. The achievement not only highlights the ingenuity of the scientists involved but also underscores the growing role of interdisciplinary collaboration in solving complex biomedical challenges.